{"id":1081,"date":"2019-05-02T09:47:22","date_gmt":"2019-05-02T01:47:22","guid":{"rendered":"http:\/\/www.bioactivescreeninglibrary.com\/?p=1081"},"modified":"2022-01-07T10:53:12","modified_gmt":"2022-01-07T02:53:12","slug":"classified-serotypes-revised-serotypes","status":"publish","type":"post","link":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/2019\/05\/02\/classified-serotypes-revised-serotypes\/","title":{"rendered":"Classified into seven serotypes and later revised to two serotypes"},"content":{"rendered":"<p>Because of the cross-reaction among BEV type-specific sera, it is difficult to type BEV using serological means. With the accumulation of BEV sequence data, classification of BEVs based on virus genetic variability and molecular difference becomes feasible. Based on the generally accepted definition for <a href=\"http:\/\/www.abmole.com\/products\/anemarsaponin-biii.html\">Anemarsaponin-BIII<\/a> picornavirus species and serotype, a molecular-based BEV classification by comparing the sequences from 59-UTR, the capsid protein region were established and used to classify bovine enteroviruses to BEV-Aand BEV-B, where different serotypes\/genotypes were further divided for <a href=\"http:\/\/www.abmole.com\/products\/ginsenoside-f2.html\">Ginsenoside-F2<\/a> either enterovirus E or enterovirus F. In this study, we reported the identification of a novel enterovirus E isolates HY12 from a cattle herd with an outbreak of a severe respiratory disease and enteritis in Jilin Province. In this study, we reported the isolation of an enterovirus HY12 strain from a cattle farm with an unknown disease of high morbidity and mortality. Sequencing results demonstrated that HY12 is a new isolates within enterovirus E. As far as we know, this is the first report of enterovirus E in China. Enteroviruses E and F both belong to the genus enterovirus that are etiologically associated with bovine enterovirus infections with clinical signs varying from respiratory diseases to enteritic, reproductive disease and infertility. Although there are reports neglecting the pathogenicity of BEVs, increasing reports for isolation of BEVs from respiratory and diarrheic cattle suggest the relatedness of BEV with those diseases. Our detection and isolation of bovine enterovirus HY12 in a cattle farm with severe respiratory and enteric diseases clearly indicate that HY12 might play a critical role in this outbreak as etiological agents. The classification of bovine enteroviruses undergoes an evolution since their initial discovery. Zell reported a molecularbased BEV classification system based on virus genetic variability and molecular difference, and demonstrated a congruence of this molecular-based classification with previous classification methods. Based on the generally accepted definition for picornavirus species and serotype, BEVs were classified into enterovirus Eand enterovirus Fby comparing sequences from 59-UTR, 39UTR and capsid protein region, where a different serotypes were further divided for either enterovirus E or enterovirus F. It is generally accepted that picornavirus serotypes are molecularly defined by the diversity of the capsid proteins, while the enterovirus species were determined by the less diverse non-structural protein regions. Current medical imaging technologies play a critical role in the diagnosis and management of cancer patients. Magnetic resonance imaging, for example, is a non-irradiative wholebody imaging platform that enables accurate localization and sensitive delineation of tumor masses, characterization of tumor vascularity, and non-invasive monitoring of treatment effects. Imaging also plays a key role in the clinical translation of new treatment paradigms, as a non-invasive method is ultimately desired for monitoring the progress of patients receiving therapy. However, imaging technologies that are used to test the efficacy and safety of new investigational drugs in preclinical <img src=\"http:\/\/www.abmole.com\/upload\/structure\/Prexasertib-hcl-LY2606368.gif\" align=\"right\" width=\"250\" style=\"padding:10px;\"\/>mouse models are not easily translated to human imaging. In other words, there is a gap in the technologies developed for preclinical testing and those ultimately required in the clinic. One way to close this gap is to use larger animal models.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Because of the cross-reaction among BEV type-specific sera, it is difficult to type BEV using serological means. With the accumulation of BEV sequence data, classification of BEVs based on virus genetic variability and molecular difference becomes feasible. Based on the generally accepted definition for Anemarsaponin-BIII picornavirus species and serotype, a molecular-based BEV classification by comparing &hellip; <a href=\"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/2019\/05\/02\/classified-serotypes-revised-serotypes\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Classified into seven serotypes and later revised to two serotypes&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1081"}],"collection":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/comments?post=1081"}],"version-history":[{"count":1,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1081\/revisions"}],"predecessor-version":[{"id":1082,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/1081\/revisions\/1082"}],"wp:attachment":[{"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/media?parent=1081"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/categories?post=1081"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.bioactivescreeninglibrary.com\/index.php\/wp-json\/wp\/v2\/tags?post=1081"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}